Prospect Capital Corporation (PSEC) Stock Price & Analysis
Prospect Capital Corporation (PSEC) is trading at USD 1.51, up 1.01% today, as of October 23, 2026 at 16:39 UTC (US market open; quotes may be delayed), according to Nexqual market data.
PSEC last closed at USD 1.49; today's session has ranged USD 1.48–1.51 on volume of 2,080,110 shares. Market capitalization is $803.39M, with a 52-week range of USD 1.43–3.13 (NMS). Source: Nexqual, retrieved October 23, 2026 at 16:39 UTC.
Also available as compact Markdown for AI agents: nexqual.com/PSEC.md
Key facts (PSEC)
- Valuation: P/E 5.2x (avg 7.2x at the last 1 fiscal year-ends), net debt $1.82B.
- Insider open-market purchases, last ~7 months: 6 Form 4 filings, $9.4M; 0 by opportunistic insiders, 6 by routine insiders.
- Analysts: Sell (mean 4.00 on a 1–5 scale) (1 analysts), mean target USD 2 (range 2–2).
- Total return with dividends: 1Y -33.2% vs S&P 500 +14.6%; 5Y -64.4% vs S&P 500 +77.3%.
- Next earnings: 2026-11-05, EPS estimate USD 0.1, revenue estimate $163M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (PSEC)
| USD | FY2024 | FY2024 | FY2025 | FY2025 | FY2026 | TTM |
|---|---|---|---|---|---|---|
| Net income | $263M | $234M | -$470M | -$491M | $154M | $154M |
| EPS (diluted) | $0.34 | — | -$1.35 | — | $0.06 | — |
| Cash + short-term investments | $85.9M | — | $50.8M | — | $43.6M | — |
| Total debt | $2.43B | — | $2.09B | — | $1.86B | — |
Fiscal years end Jun. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (PSEC)
P/E 5.2x · P/B 0.3x · Earnings yield 19.13% · Dividend yield (paid, TTM) 41.77% · Net debt $1.82B · EV $2.62B
P/E at fiscal year-ends: Jun 2026 7.2x.
Insider purchases (SEC Form 4, open-market, last ~7 months) (PSEC)
6 purchases, $9.4M. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-09-04 | Barry John F | CHIEF EXECUTIVE OFFICER | 1,217,105 | $2.7M | 2.24 | Routine (bought in Sep each year 2023–2025) |
| 2026-06-23 | Barry John F | CHIEF EXECUTIVE OFFICER | 1,067,648 | $2.4M | 2.27 | Routine (bought in Sep each year 2023–2025; this trade is outside those months) |
| 2026-06-22 | Barry John F | CHIEF EXECUTIVE OFFICER | 1,000,000 | $2.2M | 2.25 | Routine (bought in Sep each year 2023–2025; this trade is outside those months) |
| 2026-05-26 | Barry John F | CHIEF EXECUTIVE OFFICER | 433,000 | $1.0M | 2.32 | Routine (bought in Sep each year 2023–2025; this trade is outside those months) |
| 2026-05-22 | Barry John F | CHIEF EXECUTIVE OFFICER | 232,000 | $539K | 2.32 | Routine (bought in Sep each year 2023–2025; this trade is outside those months) |
| 2026-05-21 | Barry John F | CHIEF EXECUTIVE OFFICER | 200,000 | $452K | 2.26 | Routine (bought in Sep each year 2023–2025; this trade is outside those months) |
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (PSEC)
Consensus Sell (mean 4.00 on a 1–5 scale), 1 analysts; mean target USD 2 (low 2, high 2).
Total return (dividends reinvested) (PSEC)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | -33.2% | -64.4% |
| S&P 500 (SPY) | +14.6% | +77.3% |
| Per year | -33.2% | -18.7% |
| Volatility (annualized) | 36.4% | 29.8% |
| Max drawdown | -45.2% (Feb 2026→Oct 2026) | -67.8% (Nov 2021→Oct 2026) |
PSEC suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | Prospect Capital Management | “Prospect Capital Management, a Delaware limited partnership that is registered as an investment adviser under the Investment Advisers Act of 1940 (the "Advisers Act") manages our investments.” |
| Partner | Prospect Administration | “We are located at 10 East 40th Street, New York, New York 10016, where we occupy our office space pursuant to our Administration Agreement with Prospect Administration.” |
| Partner | InspereX | “On October 30, 2020, and as amended on February 18, 2022, October 7, 2022 and February 10, 2023, we entered into a Dealer Manager Agreement with InspereX LLC ("InspereX Dealer Manager Agreement"), pursuant to which InspereX LLC has agreed to serve as the Company's agent and dealer manager for the Company's offering of up to 10,000,000 shares, par value $0.001 per share, of 5.50% Series AA1 Preferred Stock, 5.50% S…” |
| Partner | Preferred Capital Securities | “On August 3, 2020, we entered into a Dealer Manager Agreement with Preferred Capital Securities, LLC ("PCS") (the "Original Dealer Manager Agreement"), amended and restated on February 25, 2021 and further amended on June 9, 2022, October 7, 2022, February 10, 2023, December 29, 2023, October 17, 2024, December 27, 2024, and February 10, 2026 (as so amended, the "Amended and Restated Dealer Manager Agreement"), pu…” |
| Partner | UBS Securities | “On May 19, 2021, we entered into an Underwriting Agreement with UBS Securities LLC, relating to the offer and sale of 187,000 shares, par value $0.001 per share, of Series A2 Preferred Stock, with a liquidation preference of $25.00 per share.” |
| Partner | Incapital | “On February 13, 2020, we entered into a new selling agent agreement with InspereX LLC (formerly known as "Incapital LLC") (as amended, the "Selling Agent Agreement"), authorizing the issuance and sale from time to time of up to $1,000,000 of Prospect Capital InterNotes® (collectively with previously authorized selling agent agreements, the "InterNotes® Offerings").” |
Quoted from the company's 10-K filed Aug 20, 2026.
PSEC analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.10 | $0.10 | +0.0% | $163.1M | 1 |
| Next quarter (ends Dec 2026) | $0.10 | $0.09 | +11.1% | $152.7M | 1 |
| Current fiscal year (ends Jun 2027) | $0.38 | $0.35 | +8.6% | $620.6M | 1 |
| Next fiscal year (ends Jun 2028) | $0.35 | $0.32 | +9.4% | $609.6M | 1 |
Key Statistics (as of October 23, 2026 at 16:39 UTC)
| Price | USD 1.51 |
|---|---|
| Change | ▲ 1.01% (up) |
| Previous Close | USD 1.49 |
| Open | USD 1.49 |
| Day Range | USD 1.48 – 1.51 |
| 52-Week Range | USD 1.43 – 3.13 |
| Volume | 2,080,110 shares |
| Market Cap | $803.39M |
| Exchange | NMS |
Technical Analysis (PSEC)
Nexqual's technical model rates PSEC "SELL" based on 2 bullish and 5 bearish signals across 128 daily candles, as of October 23, 2026 at 16:39 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 19.26 (oversold) |
| vs SMA50 | Below (USD 2.04) |
| MACD | -0.17 (negative) |
Analyst Ratings (PSEC)
Wall Street analysts rate PSEC "Sell" based on 1 analysts, with a mean price target of USD 2 (range USD 2–2), per Nexqual as of October 23, 2026 at 16:39 UTC.
| Consensus Rating | Sell |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 2 |
| High Target | USD 2 |
| Low Target | USD 2 |
| Buy / Hold / Sell | 0 / 0 / 1 |
Earnings (PSEC)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD 0.1 |
| Revenue Estimate | $163.14M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.15 vs est 0.11 ▲ beat |
| 2026-03-31 | USD 0.16 vs est 0.11 ▲ beat |
| 2025-12-31 | USD 0.19 vs est 0.1 ▲ beat |
| 2025-09-30 | USD 0.17 vs est 0.11 ▲ beat |
Source: Nexqual, October 23, 2026 at 16:39 UTC.
Financials & Fundamentals (PSEC)
| Total Revenue | $639.45M |
|---|---|
| Revenue Growth (latest quarter, YoY) | -6.70% |
| Gross Margin | +100.00% |
| Operating Margin | +70.34% |
| Profit Margin | +24.03% |
| ROE | +3.37% |
| Debt / Equity | 0.41 |
| Current Ratio | 1.1 |
| Total Cash | $59.66M |
| Total Debt | $1.86B |
Source: Nexqual, October 23, 2026 at 16:39 UTC.
Financial Health Score (PSEC)
Nexqual rates Prospect Capital Corporation's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 16:39 UTC.
| Growth | Critical — Revenue -11% YoY (annual), sharp decline |
|---|---|
| Profitability | Strong — Operating margin 70% |
| Balance Sheet | Solid — $44M cash and investments vs $1.86B debt (Jun 2026, SEC) |
| Cash Flow | Solid — Operating cash flow $516M (FY ended Jun 2026, 10-K) |
| Efficiency | Weak — ROE 3%, ROA 4.3% |
Ownership (PSEC)
| Insider Ownership | +25.93% |
|---|---|
| Institutional Ownership | +18.30% |
| Shares Outstanding | 533.82M |
| Short % of Float | +4.52% |
Source: Nexqual, October 23, 2026 at 16:39 UTC.
Leadership (PSEC)
Prospect Capital Corporation is led by John Francis Barry III, Chairman of the Board & CEO, per Nexqual as of October 23, 2026 at 16:39 UTC.
| Chairman of the Board & CEO | John Francis Barry III |
|---|---|
| President, COO & Director | Michael Grier Eliasek |
| CFO, Treasurer, Secretary & Chief Compliance Officer | Kristin Lea Van Dask |
| Chief Technology Officer | Al Faella |
| Managing Director | Bart J. deBie |
Major Backers & Investors (PSEC)
Notable institutional backers of Prospect Capital Corporation include Private Management Group, Inc., Two Sigma Investments, LP, Van Eck Associates Corporation, according to Nexqual as of October 23, 2026 at 16:39 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Private Management Group, Inc. | 3.85% |
| Two Sigma Investments, LP | 2.64% |
| Van Eck Associates Corporation | 1.81% |
| VanEck ETF Trust-VanEck BDC Income ETF | 1.3% |
| UBS Group AG | 1.24% |
| Gendell, Jeffrey L. | 0.75% |
| Marshall Wace LLP | 0.57% |
| Morgan Stanley | 0.5% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Legal & General Group PLC | 0.76% |
Source: Nexqual, October 23, 2026 at 16:39 UTC.
From Prospect Capital Corporation's Latest SEC 10-K Filing (filed 2026-08-20)
Partnerships
- Based on the information reviewed and the discussions detailed above, the Board of Directors (including all of the directors who are not "interested persons" as defined in the 1940 Act) concluded that the investment advisory fee rates and terms are fair and reasonable in relation to the services provided and approved the renewal of the Investment Advisory Agreement with Prospect Capital Management as being in the best interests of the Company and its stockholders.
- We have entered into an investment advisory and management agreement with the Investment Adviser (the "Investment Advisory Agreement") under which the Investment Adviser, subject to the overall supervision of our Board of Directors, manages the day-to-day operations of, and provides investment advisory services to, us.
Legal & Regulatory Risks (Item 1A, quoted)
- Trade negotiations and other government actions may create regulatory uncertainty for the portfolio companies and our investment strategy and adversely affect the profitability of the portfolio companies.
- Regulations governing our operation as a BDC affect our ability to raise, and the way in which we raise, additional capital. These constraints may hinder our Investment Adviser's ability to take advantage of attractive investment opportunities and to achieve our investment objective.
- Changes in the laws or regulations governing our business or the businesses of our portfolio companies and any failure by us or our portfolio companies to comply with these laws or regulations could negatively affect the profitability of our operations or the profitability of our portfolio companies.
- Changes in laws and regulations, as well as their interpretations, may adversely affect their business, financial structure or prospects.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BXSL | Blackstone Secured Lending Fund | USD 23.54 | ▼ 1.57% |
| VCTR | Victory Capital Holdings, Inc. | USD 107.21 | ▼ 0.17% |
| PDI | PIMCO Dynamic Income Fund | USD 14.32 | ▲ 0.14% |
| AMG | Affiliated Managers Group, Inc. | USD 389.68 | ▼ 1.48% |
| SEIC | SEI Investments Company | USD 103.31 | ▼ 1.14% |
| IVZ | Invesco Ltd | USD 28.51 | ▼ 0.97% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 16:39 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt